{"schema_version":"secwatch.filing_event.v1","accession":"0000049071-23-000046","form_type":"8-K","ticker":"HUM","cik":"0000049071","company_name":"HUMANA INC","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.368411+00:00","generated_at":"2026-06-12T15:18:51.795292+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Humana Q2 adjusted EPS $8.94 beats $8.76 YoY; affirms FY adjusted EPS at least $28.25","bullets":["GAAP EPS $7.66 vs $5.48 YoY; adjusted EPS $8.94 vs $8.76; revenue $26.7B (+13% GAAP).","FY 2023 GAAP EPS guidance revised to at least $26.91 from at least $27.88; adjusted EPS affirmed at at least $28.25.","Individual Medicare Advantage membership growth raised by 50k to ~825k (18% growth), above industry.","Benefits expense ratio guidance affirmed at 86.3%-87.3%; CEO cites stabilizing utilization.","Mid-term adjusted EPS target of $37 in 2025 reiterated; recent Medicaid wins in Indiana and Oklahoma."],"urls":{"canonical":"https://secwatch.observer/filing/0000049071-23-000046","json":"https://secwatch.observer/filing/0000049071-23-000046.json","markdown":"https://secwatch.observer/filing/0000049071-23-000046.md","text":"https://secwatch.observer/filing/0000049071-23-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000046/0000049071-23-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000046/hum-20230802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T15:18:51.795292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7cbf6a1cbeb9bdb3b7fa66a32361afe206822a4b","claim":"HUMANA INC reported the quarter ended June 30, 2023 (2Q23) results: revenue $26,747, EPS $7.66.","evidence_excerpt":"by Humana on February 23, 2023 . 2 Humana Inc. Summary of Results ($ in millions, except per share amounts) 2Q23 (a) 2Q22 (b) YTD 2023 (c) YTD 2022 (d) CONSOLIDATED Revenues $26,747 $23,662 $53,489 $47,632 Revenues - Adjusted (non-GAAP) $25,733 $22,540 $51,385 $45,402 Pretax results $1,262 $1,122 $2,876 $2,342 Pretax results - Adjusted (non-GAAP) $1,470","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000046/0000049071-23-000046-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023 (2Q23)"},{"label":"Revenue","value":"$26,747"},{"label":"EPS","value":"$7.66"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}